Experiment 1324075
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | EXTERNAL |
| Organism | Allium ampeloprasum (LILIACEAE) |
| Citation | MOSAVAT,SH: GHAHRAMANI,L: ZAHRA SOBHANI,Z: HAGHIGHI,ER: HEYDARI,M:. (2015). TOPICAL ALLIUM AMPELOPRASUM SUBSP IRANICUM (LEEK) EXTRACT CREAM IN PATIENTS WITH SYMPTOMATIC HEMORRHOIDS: A PILOT RANDOMIZED AND CONTROLLED CLINICAL TRIAL. 20(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE STUDY WAS DESIGNED AS A 2-ARM, DOUBLE-BLIND RANDOMIZED AND CONTROLLED CLINICAL TRIAL USING A PARALLEL DESIGN WITH A 1:1 ALLOCATION RATIO. THE PATIENTS RECRUITED WERE RANDOMLY ASSIGNED TO RECEIVE LEEK CREAM (N = 10) AS PART OF THE INTERVENTION GROUP OR ANTIHEMORRHOID CREAM (WITH 5% LIDOCAINE, N = 10) AS PART OF THE CONTROL GROUP FOR A PERIOD OF 3 WEEKS. PATIENTS RECEIVED 2 CC OF THE LEEK CREAM OR STANDARD TOPICAL ANTIHEMORRHOID CREAM TWICE DAILY FOR 3 WEEKS. PATIENTS WERE EVALUATED PRIOR TO AND FOLLOWING 3 WEEKS OF THE INTERVENTION IN TERMS OF THE FOLLOWING ITEMS: 1. PAIN (11-GRADE VISUAL ANALOGUE SCALE, 0-10) 2. DEFECATION DISCOMFORT (11-GRADE VISUAL ANALOGUE SCALE, 0-10) 3. BLEEDING SEVERITY (5-GRADE SCORING SYSTEM, 0-4) 4. ANAL ITCHING SEVERITY (5-GRADE SCORING SYSTEM, 0-4) 5. OVERALL SUBJECTIVE IMPROVEMENT (%) 6. NUMBER OF PARTICIPANTS WITH ANY OBSERVED OR REPORTED ADVERSE EVENTS THE PILOT STUDY HAS SHOWN THAT TOPICAL USE OF LEEK EXTRACT CREAM CAN BE AS EFFECTIVE AS AN ESTABLISHED ANTIHEMORRHOID CREAM IN THE ALLEVIATION OF HEMORRHOIDAL DISEASES. |
| Dose amount | 4 ML |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |